v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance (in shares) at Dec. 31, 2023   12,349,243    
Balance at Dec. 31, 2023 $ (2,131,818) $ 12,349 $ 102,238,382 $ (104,382,549)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
PIPE Financing and Issuance of Common Stock and Warrants, net of equity issuance costs (in shares)   15,713,664    
PIPE Financing and Issuance of Common Stock and Warrants, net of issuance costs 83,556,563 $ 15,714 83,540,849  
Stock-based compensation expense (in shares)   639,664    
Stock-based compensation expense 8,317,480 $ 640 8,316,840  
Common stock issued in acquisition (in shares)   1,605    
Common stock issued in acquisition 5,618 $ 2 5,616  
Warrant exercises (in shares)   1,301,410    
Warrant exercises 0 $ 1,301 (1,301)  
Conversion of multi-draw credit agreement - related party and accrued interest (in shares)   968,973    
Conversion of convertible note - related Party 4,971,004 $ 969 4,970,035  
Net loss for the year ended (26,567,123)     (26,567,123)
Balance (in shares) at Dec. 31, 2024   30,974,559    
Balance at Dec. 31, 2024 68,151,724 $ 30,975 199,070,421 (130,949,672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense (in shares)   10,625    
Stock-based compensation expense 7,767,694 $ 11 7,767,683  
Purchases under employee stock purchase plan (in shares)   18,461    
Purchases under employee stock purchase plan 29,571 $ 18 29,553  
Warrant exercises (in shares)   2,374,494    
Warrant exercises 0 $ 2,375 (2,375)  
Net loss for the year ended (55,924,814)     (55,924,814)
Balance (in shares) at Dec. 31, 2025   33,378,139    
Balance at Dec. 31, 2025 $ 20,024,175 $ 33,379 $ 206,865,282 $ (186,874,486)